Complement factor H polymorphism p.Tyr402His and cuticular drusen

Archives of Ophthalmology

Volumn 125, Issue 1, 2007, Pages 93-97

  Grassi, Michael A ^a,b   Folk, James C ^a,e   Scheetz, Todd E ^a,c,e   Taylor, Christine M ^a   Sheffield, Val C ^a,c,d,e   Stone, Edwin M ^a,c,d,e  

^a UNIVERSITY OF IOWA   (United States)

^b Heed Ophthalmic Foundation   (United States)

^c Center for Bioinformatics and Computational Biology   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; HISTIDINE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA SEQUENCE; FISHER EXACT TEST; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHOTOGRAPHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RETINA MACULA DEGENERATION;

ADULT; AGED; AGED, 80 AND OVER; COMPLEMENT FACTOR H; FEMALE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINAL DRUSEN;

EID: 33846071006     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.1.93     Document Type: Article

References (26)

1. Friedman DS, O'Colmain BJ, Munoz B, et al; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
2. Kenyon KR, Maumenee AE, Ryan SJ, Whitmore PV, Green WR. Diffuse drusen and associated complications. Am J Ophthalmol. 1985;100:119-128.
3. Gass JD, Jallow S, Davis B. Adult vitelliform macular detachment occurring in patients with basal laminar drusen. Am J Ophthalmol. 1985;99:445-459.
4. Gass JDM. Basal Laminar Drusen and Macular Degeneration: Stereoscopic Atlas of Macular Diseases Diagnosis and Treatment. 4th ed. St Louis, Mo: Mosby; 1997:106-111.
5. Russell SR, Mullins RF, Schneider BL, Hageman GS. Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol. 2000;129:205-214.
6. Leys A, Proesmans W, Van Damme-Lombaerts R, Van Damme B. Specific eye fundus lesions in type II membranoproliferative glomerulonephritis [erratum appears in Pediatr Nephrol 1991 May;5:364]. Pediatr Nephrol. 1991;5:189-192.
7. Leys A, Vanrenterghem Y, Van Damme B, Snyers B, Pirson Y, Leys M. Fundus changes in membranoproliferative glomerulonephritis type II: a fluorescein angiographic study of 23 patients. Graefes Arch Clin Exp Ophthalmol. 1991;229:406-410.
8. Leys A, Van Damme B, Verberckmoes R. Ocular complications of type 2 membranoproliferative glomerulonephritis. Nephrol Dial Transplant. 1996;11:211-214.
9. Leys A, Vanrenterghem Y, Van Damme B, Snyers B, Pirson Y, Leys M. Sequential observation of fundus changes in patients with long standing membranoproliferative glomerulonephritis type II (MPGN type II). Eur J Ophthalmol. 1991;1:17-22.
10. Michielsen B, Leys A, Van Damme B, Missotten L. Fundus changes in chronic membranoproliferative glomerulonephritis type II. Doc Ophthalmol. 1990;76:219-229.
11. Leys A, Michielsen B, Leys M, Vanrenterghem Y, Missotten L, Van Damme B. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II. Graefes Arch Clin Exp Ophthalmol. 1990;228:499-504.
12. O'Brien C, Duvall-Young J, Brown M, Short C, Bone M. Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities. Br J Ophthalmol. 1993;77:778-780.
13. McAvoy CE, Silvestri G. Retinal changes associated with type 2 glomerulonephritis. Eye. 2005;19:985-989.
14. Mullins RF, Aptsiauri N, Hageman GS. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye. 2001;15:390-395.
15. Hogasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest. 1995;95:1054-1061.
16. Levy M, Halbwachs-Mecarelli L, Gubler MC, et al. H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int. 1986;30:949-956.
17. Pickering MC, Cook HT, Warren J, et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet. 2002;31:424-428.
18. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005;102:7227-7232.
19. Edwards AO, Ritter IIIR, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
20. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
21. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.
22. Buffone GJ, Darlington GJ. Isolation of DNA from biological specimens without extraction with phenol. Clin Chem. 1985;31:164-165.
23. Russell SR, Gupta RR, Folk JC, Mullins RF, Hageman GS. Comparison of color to fluorescein angiographic images from patients with early-adult onset grouped drusen suggests drusen substructure. Am J Ophthalmol. 2004;137:924-930.
24. Stone EM, Braun TA, Russell SR, et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med. 2004;351:346-353.
25. Lotery AJ, Baas D, Ridley C, et al. Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa. Hum Mutat. 2006;27:568-574.
26. Cohen SY, Meunier I, Soubrane G, Glacet-Bernard A, Coscas GJ. Visual function and course of basal laminar drusen combined with vitelliform macular detachment. Br J Ophthalmol. 1994;78:437-440.